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proteins of different mol. wt. (250,000 to
45,000 daltons) from the surface of trans-
formed cells.
To conclude, this is a collection of papers
of high quality, giving a very useful survey
of areas of growth in our knowledge of cell
surface structure and function. The value
of the book greatly exceeds the price
(only $5.60).
M. MOORE
Recent Topics in Chemical Carcino-
genesis. Gann Monographs on Cancer
Research, No. 17. (1975) Eds S. ODA-
SHIMA, S. TAKAYAMA and H. SATO. Balti-
more: University Park Press. pp. 456.
£27.95 net.
This monograph is dedicated to Professor
Tomizo Yoshida, and the preface includes
tributes from British, German, Japanese and
American colleagues.
The book contains many excellent papers
and the quality ofthe presentation, including
the microphotos, is of a high standard,
although unfortunately there are a number
of minor errors in the text. The topics
are grouped under four headings: Muta-
genicity and in vitro carcinogenesis; Chemis-
try and metabolism ofN-nitroso compounds;
Environmental carcinogenesis, and Experi-
mental models oftumours in various organs.
The most comprehensive section is the
fourth, in which animal studies of tumours
of the stomach, duodenum, liver, kidney,
bladder and skin are presented, together
with papers on experimentally induced leuk-
aemias. In general, however, more care
should have been taken in grouping the
papers in the different sections. There is
an obvious mistake in which the section
on chemistry and metabolism of N-nitroso
compounds should have begun with Pro-
fessor Druckrey's paper and not included
the papers on in vitro studies. It would
also have been more appropriate to open
the first section with Dr Kuroki's review
on contributions of tissue culture to the
study of chemical carcinogenesis, to be
followed by other papers on in vitro aspects
and end this section with the studies of
mutagenicity.
On balance, this monograph would seem
an expensive investment as, although there
is a considerable amount of valuable in-
formation, the price of £27.95 is high.
A. W. CRAIG
WHO Handbookfor Standardised Cancer
Registries. (WHO Offset Publication
No. 25) (1976). Geneva: World Health
Organization. pp. 94. Price Sw. Fr. 10;
US $4.00.
Although many cancer registries were
originally set up by individual hospitals
to gather data on the outcome of treatment
in their own patients, there is much to be
gained by comparing and pooling the data
of different hospitals. For example, if this
can be done for all the hospitals serving a
given population, and if cancer patients
from this population who have not been
to hospital can also be ascertained, incidence
as well as outcome can be examined. And
if such data can be gathered in a sufficiently
standard form to allow incidence and out-
come in different populations to be compared,
points at which there is scope for improving
prevention or treatment may be identified.
An internationally representative group
of distinguished experts, which met under
World Health Organization auspices to
consider how the data of different registries
might be made easier to compare, has now
produced this Handbook, recommending
what data should be collected and how some
of these data should be coded. Two kinds
of data are distinguished:
(a) core data (sufficient to fill one 80-
column punch card) which it is
considered that every hospital-based
registry should record, including pa-
tient identification particulars; site,
type, extent, and date and method
of diagnosis of neoplasm; date of
presentation at hospital; modalities
of treatment; and follow-up data;
(b) optional data on other matters that
may be related to incidence or
outcome.
According to a correction slip enclosed
with the Handbook, the phrase " (Hospital-
Based) " should be added to the title as
printed, but it would be wrong to conclude
from this that the recommendations are
not relevant to population-based registries.
True, even the " core data " are not all